Patent · US Active

Modified tuberculosis antigens

US8932600B2 · kind B2 · utility

2Cited by

20References

25Claims

0Family size

Assignees

GLAXOSMITHKLINE BIOLOGICALS SA · BE
Glaxo Group Limited · GB

Inventors

Normand Blais · Laval, CA
James Raymond Brown · Berwyn, US
Anne-Marie Gelinas · Laval, CA
Pascal Mettens · Rixensart, BE
Dennis Murphy · Collegeville, US

Key dates

Filing date	Jan 27, 2011
Grant date	Jan 13, 2015
Priority date	—
Expiry date	Jan 27, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Modified Rv3616c proteins and their use as medicaments, particularly for the prevention of reactivation of tuberculosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.